Hugh W Hoogendoorn

Title: Hugh W Hoogendoorn: Innovator in Antithrombin Activity Measurement

Introduction

Hugh W Hoogendoorn is a notable inventor based in Ancaster, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of antithrombin activity. His innovative approach has the potential to enhance the accuracy of coagulation assessments.

Latest Patents

Hugh W Hoogendoorn holds a patent for a method of measuring antithrombin (AT) activity. This invention provides a one-stage method that involves mixing a diluted sample with AT-deficient plasma containing intrinsic coagulation enzymes, an AT augmenting compound such as heparin, a phospholipid, and an activator of the contact phase of the intrinsic coagulation pathway. Following the addition of calcium ions, the coagulation time is measured and compared to a reference standard to determine the level of AT activity in the sample. This method represents a significant advancement in the field of hematology.

Career Highlights

Throughout his career, Hugh W Hoogendoorn has focused on developing innovative solutions for medical diagnostics. His work has been instrumental in improving the understanding and measurement of coagulation factors, which are critical in various medical conditions.

Collaborations

Hugh has collaborated with notable professionals in his field, including Alexander Duncan and Michael J Morris. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Hugh W Hoogendoorn's contributions to the measurement of antithrombin activity highlight his innovative spirit and dedication to improving medical diagnostics. His work continues to influence the field and pave the way for future advancements.